In some preclinical studies, MTDH-based DNA vaccines have been shown to induce the antitumour function of cytotoxic T lymphocytes and CD8+ T cells, and treatment with these vaccines inhibits tumour growth and metastasis in prostate cancer and enhances chemosensitivity to paclitaxel with minimal adverse effects32,33. Here, CD8A is linked to prostate cancer.